This paper, written by an international team of researchers, documents the work of the African AIDS Vaccine Programme (AAVP). It highlights the programme's impacts, successes and challenges, and looks to where the AAVP is heading.

The AAVP, supported by the WHO and UNAIDS, is a network of African HIV vaccine stakeholders that promotes a coordinated approach to developing HIV vaccines and making them available on the continent. It operates through collaborative centres located at key institutions across Africa.

Programme members work on crucial issues including regulation; ethics, laws and human rights in clinical trials; biomedical research; country-based strategic planning; and communication and media.

The authors outline the AAVP's achievements to date, highlighting its success in expanding training and infrastructure specific to HIV vaccine development. They suggest that AAVP could offer a way for African stakeholders to influence the global agenda for HIV vaccine research and development.

Go to key document